Editorial response: Discordance between virological, immunologic, and clinical outcomes of therapy with protease inhibitors among human immunodeficiency virus-infected patients

被引：6
|
作者：
Goetz, MB
机构：
[1] Vet Adm Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
来源：
CLINICAL INFECTIOUS DISEASES | 1999年 / 29卷 / 06期
关键词：
D O I：
10.1086/313563
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1431 / 1434
页数：4
相关论文
共 50 条
  • [21] Immunologic Response to Oral Polio Vaccine in Human Immunodeficiency Virus-infected and Uninfected Zimbabwean Children
    Gnanashanmugam, Devasena
    Troy, Stephanie B.
    Musingwini, Georgina
    Huang, ChunHong
    Halpern, Meira S.
    Stranix-Chibanda, Lynda
    Shetty, Avinash K.
    Kouiavskaia, Diana
    Nathoo, Kusum
    Chumakov, Konstantin
    Maldonado, Yvonne A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 176 - 180
  • [22] Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen
    Piketty, C
    Weiss, L
    Thomas, F
    Mohamed, AS
    Belec, L
    Kazatchkine, MD
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (09): : 1328 - 1335
  • [23] Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria
    Agaba, Patricia A.
    Meloni, Seema T.
    Sule, Halima M.
    Agbaji, Oche O.
    Sagay, Atiene S.
    Okonkwo, Prosper
    Idoko, John A.
    Kanki, Phyllis J.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (02):
  • [24] Pneumococcal vaccine response in human immunodeficiency virus-infected patients - Reply
    Janoff, EN
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03): : 778 - 778
  • [25] Clinical Characteristics and Prognosis of Penicilliosis among Human Immunodeficiency Virus-Infected Patients in Eastern China
    Chen, Jun
    Zhang, Renfang
    Shen, Yinzhong
    Liu, Li
    Qi, Tangkai
    Wang, Zhenyan
    Song, Wei
    Tang, Yang
    Lu, Hongzhou
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 96 (06): : 1350 - 1354
  • [26] Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy
    Grimes, RM
    Otiniano, ME
    Rodriguez-Barradas, MC
    Lai, DJ
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (11) : 1530 - 1533
  • [27] Erythropoietin response to anemia among human immunodeficiency virus-infected infants in Malawi
    Semba, RD
    Broadhead, R
    Taha, TE
    Totin, D
    Ricks, MO
    Kumwenda, N
    HAEMATOLOGICA, 2001, 86 (11) : 1221 - 1222
  • [28] Darunavir Inhibitory Quotient Predicts the 48-Week Virological Response to Darunavir-Based Salvage Therapy in Human Immunodeficiency Virus-Infected Protease Inhibitor-Experienced Patients
    Molto, Jose
    Santos, Jose R.
    Perez-Alvarez, Nuria
    Cedeno, Samandhy
    Miranda, Cristina
    Khoo, Saye
    Else, Laura
    Llibre, Josep Maria
    Valle, Marta
    Clotet, Bonaventura
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 3928 - 3932
  • [29] PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 REGULATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS UNDER PROTEASE INHIBITORS
    Boccara, Franck
    Ghislain, Mathilde
    Meyer, Laurence
    Goujard, Cecile
    Le May, Cedric
    Vigouroux, Corinne
    Bastard, Jean Philippe
    Fellahi, Soraya
    Capeau, Jacqueline
    Cohen, Ariel
    Cariou, Bertrand
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1659 - 1659
  • [30] Commentary: Immunologic Response to Oral Polio Vaccine in Human Immunodeficiency Virus-infected and Uninfected Zimbabwean Children
    Jafari, Hamid S.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 181 - 183
12345